Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center

Rubino, Claudia; Blunda, Fabiana; Bodega, Francesca; Melillo, Francesco; Russi, Anita; Mattiello, Paolo; Salerno, Anna; Cera, Michela; Margonato, Davide; Mazzone, Patrizio; Della Bella, Paolo; Castiglioni, Alessandro; Alfieri, Ottavio; De Bonis, Michele; Montorfano, Matteo; Filippi, Massimo; Tresoldi, Moreno; Cappelletti, Alberto; Zangrillo, Alberto; Margonato, Alberto; Godino, Cosmo

doi:10.23736/S0026-4806.21.07432-2

Limited real-world data are available regarding the comparison about safety and efficacy of DOACs prescription in very elderly patients (≥85 years) with non-valvular atrial fibrillation (NVAF). Concern about the risk of bleeding with anticoagulation in very older patients still represents an important challenge for clinicians.

Safety and efficacy of Direct Oral Anticoagulants (DOACs) in very elderly patients (≥ 85 years old) with non-valvular atrial fibrillation. The Experience of an Italian tertiary care center / Rubino, Claudia; Blunda, Fabiana; Bodega, Francesca; Melillo, Francesco; Russi, Anita; Mattiello, Paolo; Salerno, Anna; Cera, Michela; Margonato, Davide; Mazzone, Patrizio; Della Bella, Paolo; Castiglioni, Alessandro; Alfieri, Ottavio; De Bonis, Michele; Montorfano, Matteo; Filippi, Massimo; Tresoldi, Moreno; Cappelletti, Alberto; Zangrillo, Alberto; Margonato, Alberto; Godino, Cosmo. - In: MINERVA MEDICA. - ISSN 1827-1669. - 114:2(2023), pp. 137-147. [10.23736/S0026-4806.21.07432-2]